Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 2

Review Article

Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis

Table 2

The quantitative analysis of common pneumonia and COVID-19 pneumonia.

SubjectEfficacy indexEffect value95% CIPEffect valueHeterogeneityM
I2P

Common pneumoniaFlu-like symptomsWMD = −1.81−2.12, −1.50<0.00198.0<0.001R
FeverWMD = −1.58−1.99, −1.17<0.00198.3<0.001R
CoughWMD = −2.07−2.57, −1.57<0.00197.7<0.001R
SputumWMD = −1.10−1.50, −0.70<0.00162.20.047R
Pulmonary ralesWMD = −2.03−2.74, −1.31<0.00197.1<0.001R
Pulmonary imaging improvementWMD = −1.88−2.28, −1.47<0.00156.50.032R
Curative effectOR = 3.652.81, 4.76<0.0010.00.945F
Healing periodWMD = −1.68−2.62, −0.74<0.00197.0<0.001R

COVID-19 pneumoniaFlu-like symptomsOR = 3.182.36, 4.29<0.0016.70.367F
FeverOR = 4.051.78, 6.59<0.0010.00.548F
CoughOR = 3.431.87, 6.29<0.0017.70.338F
Sore throatOR = 0.310.03, 2.990.31439.80.197F
NauseaOR = 1.980.49, 7.950.3367.40.340F
DiarrhoeaOR = 1.280.18, 9.300.8100.00.638F
Loss of appetiteOR = 6.050.69, 53.140.10474.50.020R
FatigueOR = 2.821.44, 5.530.0030.00.757F
Muscle painOR = 5.011.44, 17.400.0110.00.723F
HeadacheOR = 2.670.30, 23.830.3780.00.938F
SputumOR = 4.301.01, 18.220.04861.90.073R
Shortness of breathOR = 10.623.71, 30.40<0.0010.00.751F
BreathlessnessOR = 4.810.97, 23.860.0550.00.672F
Chest tightnessOR = 3.021.23, 7.420.01631.50.232F
Pulmonary imaging improvementOR = 1.771.29, 2.42<0.00143.70.130F
Curative effectOR = 2.491.76–3.53<0.00129.80.234F
Healing periodWMD = −2.06−3.36, 0.750.0020.00.810F
Conversion of severe casesOR = 0.460.27, 0.770.00318.20.295F

AllAdverse reactionsOR = 0.740.56, 0.970.0290.00.994F
Common pneumoniaOR = 0.750.54, 1.050.0970.00.992F

M, model; R, random-effects model; F, fixed-effects model.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.